We now have clinical trials with 4 oral anticoagulants for stroke prevention in a-fib. Which will become the standard of care?

Print
Apixaban
55% (6 votes)
Dabigatran
9% (1 vote)
Rivaroxaban
9% (1 vote)
Warfarin
27% (3 votes)
Total votes: 11